Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

MSPR vs DBVT vs ALKS vs CLCO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MSPR
MSP Recovery, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$47M
5Y Perf.-99.8%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.+546.9%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+23.1%
CLCO
Cool Company Ltd.

Marine Shipping

IndustrialsNYSE • BM
Market Cap$511M
5Y Perf.+21.4%

MSPR vs DBVT vs ALKS vs CLCO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MSPR logoMSPR
DBVT logoDBVT
ALKS logoALKS
CLCO logoCLCO
IndustryMedical - Healthcare Information ServicesBiotechnologyBiotechnologyMarine Shipping
Market Cap$47M$1712.35T$5.90B$511M
Revenue (TTM)$10M$0.00$1.56B$331M
Net Income (TTM)$-719M$-168M$153M$59M
Gross Margin26.3%65.4%61.8%
Operating Margin-127.9%12.3%43.1%
Forward P/E24.8x12.1x
Total Debt$795M$22M$70M$1.31B
Cash & Equiv.$12M$194M$1.12B$165M

MSPR vs DBVT vs ALKS vs CLCOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MSPR
DBVT
ALKS
CLCO
StockDec 24May 26Return
MSP Recovery, Inc. (MSPR)1000.2-99.8%
DBV Technologies S.… (DBVT)100646.9+546.9%
Alkermes plc (ALKS)100123.1+23.1%
Cool Company Ltd. (CLCO)100121.4+21.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: MSPR vs DBVT vs ALKS vs CLCO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CLCO leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. MSP Recovery, Inc. is the stronger pick specifically for growth and revenue expansion. DBVT and ALKS also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MSPR
MSP Recovery, Inc.
The Income Pick

MSPR is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 1 yrs, beta 1.33
  • 136.8% revenue growth vs DBVT's -100.0%
Best for: income & stability
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.4% vs MSPR's -99.7%
Best for: momentum
ALKS
Alkermes plc
The Growth Play

ALKS is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • 5.4% ROA vs DBVT's -89.0%
Best for: growth exposure and sleep-well-at-night
CLCO
Cool Company Ltd.
The Long-Run Compounder

CLCO carries the broadest edge in this set and is the clearest fit for long-term compounding and defensive.

  • 1.9% 10Y total return vs ALKS's -11.0%
  • Beta 0.16, yield 14.2%, current ratio 0.73x
  • Lower P/E (12.1x vs 24.8x)
  • 17.8% margin vs MSPR's -73.3%
Best for: long-term compounding and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthMSPR logoMSPR136.8% revenue growth vs DBVT's -100.0%
ValueCLCO logoCLCOLower P/E (12.1x vs 24.8x)
Quality / MarginsCLCO logoCLCO17.8% margin vs MSPR's -73.3%
Stability / SafetyCLCO logoCLCOBeta 0.16 vs MSPR's 1.33
DividendsCLCO logoCLCO14.2% yield; the other 3 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs MSPR's -99.7%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

MSPR vs DBVT vs ALKS vs CLCO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MSPRMSP Recovery, Inc.

Segment breakdown not available.

DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
CLCOCool Company Ltd.
FY 2024
Time And Voyage Charter
100.0%$314M

MSPR vs DBVT vs ALKS vs CLCO — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGCLCO

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. CLCO is the more profitable business, keeping 17.8% of every revenue dollar as net income compared to MSPR's -73.3%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMSPR logoMSPRMSP Recovery, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCLCO logoCLCOCool Company Ltd.
RevenueTrailing 12 months$10M$0$1.6B$331M
EBITDAEarnings before interest/tax-$659M-$112M$212M$222M
Net IncomeAfter-tax profit-$719M-$168M$153M$59M
Free Cash FlowCash after capex-$11M-$151M$392M-$348M
Gross MarginGross profit ÷ Revenue+26.3%+65.4%+61.8%
Operating MarginEBIT ÷ Revenue-127.9%+12.3%+43.1%
Net MarginNet income ÷ Revenue-73.3%+9.8%+17.8%
FCF MarginFCF ÷ Revenue-107.9%+25.1%-105.0%
Rev. Growth (YoY)Latest quarter vs prior year-94.6%+28.2%+9.9%
EPS Growth (YoY)Latest quarter vs prior year-3.2%+91.5%-4.1%-100.0%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — DBVT and CLCO each lead in 2 of 4 comparable metrics.

At 5.3x trailing earnings, CLCO trades at a 79% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, CLCO's 7.4x EV/EBITDA is more attractive than ALKS's 17.3x.

MetricMSPR logoMSPRMSP Recovery, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCLCO logoCLCOCool Company Ltd.
Market CapShares × price$47M$1712.35T$5.9B$511M
Enterprise ValueMkt cap + debt − cash$830M$1712.35T$4.9B$1.7B
Trailing P/EPrice ÷ TTM EPS-0.00x-0.76x24.76x5.31x
Forward P/EPrice ÷ next-FY EPS est.12.09x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.25x7.41x
Price / SalesMarket cap ÷ Revenue2.59x4.00x1.59x
Price / BookPrice ÷ Book value/share0.66x3.28x0.68x
Price / FCFMarket cap ÷ FCF12.28x
Evenly matched — DBVT and CLCO each lead in 2 of 4 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLCO's 1.72x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs MSPR's 2/9, reflecting strong financial health.

MetricMSPR logoMSPRMSP Recovery, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCLCO logoCLCOCool Company Ltd.
ROE (TTM)Return on equity-55.9%-130.2%+8.8%+7.5%
ROA (TTM)Return on assets-41.4%-89.0%+5.4%+2.6%
ROICReturn on invested capital-69.7%+18.9%+6.7%
ROCEReturn on capital employed-67.7%-145.7%+14.2%+8.7%
Piotroski ScoreFundamental quality 0–92475
Debt / EquityFinancial leverage0.13x0.04x1.72x
Net DebtTotal debt minus cash$782M-$172M-$1.0B$1.1B
Cash & Equiv.Liquid assets$12M$194M$1.1B$165M
Total DebtShort + long-term debt$795M$22M$70M$1.3B
Interest CoverageEBIT ÷ Interest expense-2.49x-189.82x32.30x1.36x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $23 for MSPR. Over the past 12 months, DBVT leads with a +110.4% total return vs MSPR's -99.7%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs MSPR's -86.8% — a key indicator of consistent wealth creation.

MetricMSPR logoMSPRMSP Recovery, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCLCO logoCLCOCool Company Ltd.
YTD ReturnYear-to-date-58.4%+4.9%+25.3%+0.3%
1-Year ReturnPast 12 months-99.7%+110.4%+16.5%+62.5%
3-Year ReturnCumulative with dividends-99.8%+19.7%+14.5%+6.2%
5-Year ReturnCumulative with dividends-99.8%-69.1%+60.9%+1.9%
10-Year ReturnCumulative with dividends-99.8%-87.0%-11.0%+1.9%
CAGR (3Y)Annualised 3-year return-86.8%+6.2%+4.6%+2.0%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ALKS and CLCO each lead in 1 of 2 comparable metrics.

CLCO is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than MSPR's 1.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs MSPR's 0.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMSPR logoMSPRMSP Recovery, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCLCO logoCLCOCool Company Ltd.
Beta (5Y)Sensitivity to S&P 5001.33x1.26x1.06x0.16x
52-Week HighHighest price in past year$14.00$26.18$36.60$10.00
52-Week LowLowest price in past year$0.03$7.53$25.17$5.78
% of 52W HighCurrent price vs 52-week peak+0.3%+76.3%+96.7%+96.7%
RSI (14)Momentum oscillator 0–10050.448.160.241.8
Avg Volume (50D)Average daily shares traded46K252K2.3M104K
Evenly matched — ALKS and CLCO each lead in 1 of 2 comparable metrics.

Analyst Outlook

MSPR leads this category, winning 1 of 1 comparable metric.

Analyst consensus: DBVT as "Buy", ALKS as "Buy", CLCO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). CLCO is the only dividend payer here at 14.24% yield — a key consideration for income-focused portfolios.

MetricMSPR logoMSPRMSP Recovery, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCLCO logoCLCOCool Company Ltd.
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$46.33$44.00
# AnalystsCovering analysts15281
Dividend YieldAnnual dividend ÷ price+14.2%
Dividend StreakConsecutive years of raises1000
Dividend / ShareAnnual DPS$1.38
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%
MSPR leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DBVT leads in 1 (Total Returns). 2 tied.

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

MSPR vs DBVT vs ALKS vs CLCO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MSPR or DBVT or ALKS or CLCO a better buy right now?

For growth investors, MSP Recovery, Inc.

(MSPR) is the stronger pick with 136. 8% revenue growth year-over-year, versus -10. 8% for Cool Company Ltd. (CLCO). Cool Company Ltd. (CLCO) offers the better valuation at 5. 3x trailing P/E (12. 1x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MSPR or DBVT or ALKS or CLCO?

On trailing P/E, Cool Company Ltd.

(CLCO) is the cheapest at 5. 3x versus Alkermes plc at 24. 8x.

03

Which is the better long-term investment — MSPR or DBVT or ALKS or CLCO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -99. 8% for MSP Recovery, Inc. (MSPR). Over 10 years, the gap is even starker: CLCO returned +1. 9% versus MSPR's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MSPR or DBVT or ALKS or CLCO?

By beta (market sensitivity over 5 years), Cool Company Ltd.

(CLCO) is the lower-risk stock at 0. 16β versus MSP Recovery, Inc. 's 1. 33β — meaning MSPR is approximately 729% more volatile than CLCO relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 172% for Cool Company Ltd. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MSPR or DBVT or ALKS or CLCO?

By revenue growth (latest reported year), MSP Recovery, Inc.

(MSPR) is pulling ahead at 136. 8% versus -10. 8% for Cool Company Ltd. (CLCO). On earnings-per-share growth, the picture is similar: Alkermes plc grew EPS -34. 1% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, CLCO leads at 25. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MSPR or DBVT or ALKS or CLCO?

Cool Company Ltd.

(CLCO) is the more profitable company, earning 30. 4% net margin versus -1975. 4% for MSP Recovery, Inc. — meaning it keeps 30. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLCO leads at 50. 5% versus -69. 8% for MSPR. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MSPR or DBVT or ALKS or CLCO more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

08

Which pays a better dividend — MSPR or DBVT or ALKS or CLCO?

In this comparison, CLCO (14.

2% yield) pays a dividend. MSPR, DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is MSPR or DBVT or ALKS or CLCO better for a retirement portfolio?

For long-horizon retirement investors, Cool Company Ltd.

(CLCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 16), 14. 2% yield). Both have compounded well over 10 years (CLCO: +1. 9%, MSPR: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MSPR and DBVT and ALKS and CLCO?

These companies operate in different sectors (MSPR (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and CLCO (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MSPR is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; CLCO is a small-cap deep-value stock. CLCO pays a dividend while MSPR, DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MSPR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 15%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

CLCO

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.